BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3608841)

  • 1. [Metastases of a medullary carcinoma of the thyroid (follicular variant). Diagnosis and therapy using radioiodine].
    Ruhlmann J; Vogel J; Bockisch A; Biersack HJ
    Dtsch Med Wochenschr; 1987 Jul; 112(30):1170-2. PubMed ID: 3608841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
    Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
    Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine and radiotherapy in the management of thyroid cancers.
    Simpson WJ
    Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
    Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-iodine-absorbing metastasis of differentiated thyroid cancer--therapeutic probe with 13-cis retinoic acid].
    Kaniewski M; Czetwertyńska M; Godlewska P; Drac-Kaniewska J
    Wiad Lek; 2001; 54 Suppl 1():297-300. PubMed ID: 12182038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
    Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
    Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine therapy in differentiated thyroid carcinoma.
    Salvatori M; Rufini V; Garganese MC; Di Giuda D
    Rays; 2000; 25(2):221-38. PubMed ID: 11370540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.
    Schlumberger M; Arcangioli O; Piekarski JD; Tubiana M; Parmentier C
    J Nucl Med; 1988 Nov; 29(11):1790-4. PubMed ID: 3183748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
    Bestagno M; Campagnari G
    Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Promising radioiodine therapy of pulmonary metastases of a papillary carcinoma of the thyroid in a 12-year-old boy].
    Blattmann H; Beck A; Moser E
    Radiologe; 1992 Feb; 32(2):68-72. PubMed ID: 1565783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of iodine radioisotope therapy for lung metastasis of thyroid cancer].
    Tsyb AF; Drozdovskiĭ BI; Proshin VV
    Vopr Onkol; 1996; 42(3):73-5. PubMed ID: 8801748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
    Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
    J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
    Dottorini ME; Vignati A; Mazzucchelli L; Lomuscio G; Colombo L
    J Nucl Med; 1997 May; 38(5):669-75. PubMed ID: 9170425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The medullary (C-cell) carcinoma of the thyroid. A therapeutic dilemma].
    Schumann J; Hauk H; Leonhardi B
    Chirurg; 1977 Oct; 48(10):666-70. PubMed ID: 913180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lungs absorbed dose in radioiodine therapy of differentiated thyroid carcinoma with diffuse pulmonary metastases].
    Liu B; Zeng Y; Wang J; Zhao Z; Mu D; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):851-4. PubMed ID: 20842858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
    Liu YY; Stokkel MP; Morreau HA; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):605-9. PubMed ID: 17986279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.